Respiratory Syncytial Virus (RSV) Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029

  • Single User License $3500

Respiratory Syncytial Virus (RSV) Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029

Status : July, 2020 | Medical Devices | PPT format

Report Digest

Respiratory Syncytial Virus (RSV) Diagnostics Market: Overview

High incidence of respiratory syncytial virus (RSV) especially among infants and elderly serves as a significant growth factor for respiratory syncytial virus (RSV) diagnostics market. Respiratory syncytial virus (RSV) is a respiratory virus that occurs especially in infants and the elderly. The symptoms are usually mild and similar to a cold. It causes respiratory infections like pneumonia and bronchiolitis. A major chunk of people recover in a week or two. Children under the age of five are the most affected by this infection. Over 99 percent of respiratory syncytial virus (RSV) deaths are among the children under the age of five.

Based on technologies, the respiratory syncytial virus (RSV) diagnostics market can be classified into immunoassays, artificial intelligence, liposomes, differential light scattering, antibodies, gel microdroplets, and others.

This report on the respiratory syncytial virus (RSV) diagnostics market presents a detailed analysis of the current scenario and focuses on vital aspects like key competitors, technological advancements, and the regional landscape as well. This report can prove to be a valuable asset for market shareholders and others.

Respiratory Syncytial Virus (RSV) Diagnostics Market: Competitive Landscape

Respiratory syncytial virus (RSV) diagnostics market is highly fragmented with players ranging from domestic to the international level. The COVID-19 outbreak has created havoc in the world with a high death rate and positive patient rate. Manufacturers are focusing on technological innovations for speeding up the diagnosis of the respiratory syncytial virus. Frequent mergers and acquisitions also take place in the respiratory syncytial virus (RSV) diagnostics market. The acquisition of Sigma Aldrich by Merck KGaA is a classic instance.

Key players include Hoffmann La Roche Limited, Quidel Corporation, Coris BioConcept, Quest Diagnostics, Novartis Diagnostics, Alere Inc., Abbott Laboratories, Diasorin SPA, and Fast-track diagnostics.

Respiratory Syncytial Virus (RSV) Diagnostics Market: Key Trends

The COVID-19 outbreak has leveled up the dire need for rapid screening devices. Researchers and developers are coming up with new technologies for speeding up the COVID-19 screening process. This has prompted the manufacturers to develop devices for COVID-19 screening use after a few minor changes in the devices. Abbott Laboratories recently launched a 5-minute virus test diagnostic device and the technology is based on a common point-of-care test to detect influenza and respiratory syncytial virus. Thus, this can tap the growth rate of the respiratory syncytial virus (RSV) diagnostics market.

Also, a new finding has proved that one in five COVID-19 patients is co-infected with another respiratory virus. Thus, individuals having symptoms of respiratory syncytial virus may go for testing in large numbers. Therefore, this can boost the growth of the respiratory syncytial virus (RSV) diagnostics market.

Respiratory Syncytial Virus (RSV) Diagnostics Market: Regional Assessment

The respiratory syncytial virus (RSV) diagnostics market is regionally segmented into North America, South America, the Middle East and Africa, Asia Pacific, and Europe. North America is expected to continue its lead over the respiratory syncytial virus (RSV) diagnostics market owing to the maximum number of coronavirus cases in the U.S. and the growing infant population.

Asia Pacific is also expected to record a steady growth rate due to the population boom in countries like India and China. China, being the epicenter of the novel coronavirus disease, is expected to garner massive growth in the region. Besides, the infant population is also on the rise in China. Strong steps by governments such as generating awareness about the respiratory syncytial virus (RSV) through various initiatives may also prove a growth multiplier.

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.